Surgical Complication clinical trials

Explore recruiting surgical complication clinical trials.

Recruiting surgical complication studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Surgical Complication trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficacy and safety of octreotide in laparoscopic hepatectomy surgery: effect on blood loss, need for vasoactive drugs, transfusion requirement.

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

PUMP-IT RCT: Hepatic arterial infusion PUMP chemotherapy combined with systemic therapy versus systemic therapy alone as Induction Therapy for initially unresectable colorectal liver metastases: a randomised controlled trial

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

GLO-Surgery: Indocyanine Green and near infrared fLuorescence in paediatric Oncology surgery

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

PREPARE - Intrapapillary botulinum toxin injection for PREvention of post-surgical PAncREatic fistula

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A PHASE IB/II, OPEN-LABEL, MULTICENTER, RANDOMIZED PLATFORM STUDY EVALUATING THE EFFICACY AND SAFETY OF NEOADJUVANT IMMUNOTHERAPY COMBINATIONS IN PATIENTS WITH SURGICALLY RESECTABLE HEPATOCEULLULAR CARCINOMA (MORPHEUS-NEO HCC)

Austria, Spain, Germany, France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

SWE-NEO: Swedish NeoAdjuvant Trial Comparing anti-PD-1 Monotherapy to Combined anti-CTLA-4/anti-PD-1 blockade in Resectable Stage III Melanoma

Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

Surgical Complication trials by city

Surgical Complication in Toronto Surgical Complication in Vancouver Surgical Complication in Montreal Surgical Complication in Calgary Surgical Complication in Edmonton Surgical Complication in Ottawa Surgical Complication in Winnipeg Surgical Complication in Quebec City Surgical Complication in Hamilton Surgical Complication in Kitchener Surgical Complication in London Surgical Complication in Halifax Surgical Complication in New York Surgical Complication in Los Angeles Surgical Complication in Chicago Surgical Complication in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease